Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Nigral pathology and parkinsonian signs in elders without Parkinson disease.

Buchman AS, Shulman JM, Nag S, Leurgans SE, Arnold SE, Morris MC, Schneider JA, Bennett DA.

Ann Neurol. 2012 Feb;71(2):258-66. doi: 10.1002/ana.22588.

2.

Association of Parkinson disease risk loci with mild parkinsonian signs in older persons.

Shulman JM, Yu L, Buchman AS, Evans DA, Schneider JA, Bennett DA, De Jager PL.

JAMA Neurol. 2014 Apr;71(4):429-35. doi: 10.1001/jamaneurol.2013.6222.

3.

Locus coeruleus neuron density and parkinsonism in older adults without Parkinson's disease.

Buchman AS, Nag S, Shulman JM, Lim AS, VanderHorst VG, Leurgans SE, Schneider JA, Bennett DA.

Mov Disord. 2012 Nov;27(13):1625-31. doi: 10.1002/mds.25142.

4.

Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson's disease.

Parkkinen L, O'Sullivan SS, Collins C, Petrie A, Holton JL, Revesz T, Lees AJ.

J Parkinsons Dis. 2011;1(3):277-86. doi: 10.3233/JPD-2011-11046.

5.

Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.

Ferrer I, Martinez A, Blanco R, Dalfó E, Carmona M.

J Neural Transm (Vienna). 2011 May;118(5):821-39. doi: 10.1007/s00702-010-0482-8. Review.

PMID:
20862500
6.

Lewy bodies and olfactory dysfunction in old age.

Wilson RS, Yu L, Schneider JA, Arnold SE, Buchman AS, Bennett DA.

Chem Senses. 2011 May;36(4):367-73. doi: 10.1093/chemse/bjq139.

7.

Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra.

Greffard S, Verny M, Bonnet AM, Beinis JY, Gallinari C, Meaume S, Piette F, Hauw JJ, Duyckaerts C.

Arch Neurol. 2006 Apr;63(4):584-8.

PMID:
16606773
8.

A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.

Greffard S, Verny M, Bonnet AM, Seilhean D, Hauw JJ, Duyckaerts C.

Neurobiol Aging. 2010 Jan;31(1):99-103. doi: 10.1016/j.neurobiolaging.2008.03.015.

PMID:
18457903
9.

Fragmentation of Golgi apparatus of nigral neurons with alpha-synuclein-positive inclusions in patients with Parkinson's disease.

Fujita Y, Ohama E, Takatama M, Al-Sarraj S, Okamoto K.

Acta Neuropathol. 2006 Sep;112(3):261-5.

PMID:
16855830
10.

Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.

Dijkstra AA, Voorn P, Berendse HW, Groenewegen HJ; Netherlands Brain Bank., Rozemuller AJ, van de Berg WD.

Mov Disord. 2014 Sep;29(10):1244-51. doi: 10.1002/mds.25952.

PMID:
24996051
11.

Ageing and Parkinson's disease: substantia nigra regional selectivity.

Fearnley JM, Lees AJ.

Brain. 1991 Oct;114 ( Pt 5):2283-301.

PMID:
1933245
12.

Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.

Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL.

Brain. 2005 Nov;128(Pt 11):2654-64.

PMID:
16000336
13.

Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.

Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyman BT.

J Neuropathol Exp Neurol. 1998 Apr;57(4):334-7.

PMID:
9600226
14.

Does levodopa accelerate the pathologic process in Parkinson disease brain?

Parkkinen L, O'Sullivan SS, Kuoppamäki M, Collins C, Kallis C, Holton JL, Williams DR, Revesz T, Lees AJ.

Neurology. 2011 Oct 11;77(15):1420-6. doi: 10.1212/WNL.0b013e318232ab4c.

PMID:
21917769
15.

Formation and development of Lewy pathology: a critical update.

Jellinger KA.

J Neurol. 2009 Aug;256 Suppl 3:270-9. doi: 10.1007/s00415-009-5243-y. Review.

PMID:
19711116
16.

Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease.

Milber JM, Noorigian JV, Morley JF, Petrovitch H, White L, Ross GW, Duda JE.

Neurology. 2012 Dec 11;79(24):2307-14. doi: 10.1212/WNL.0b013e318278fe32.

17.

Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.

Schneider JA, Arvanitakis Z, Yu L, Boyle PA, Leurgans SE, Bennett DA.

Brain. 2012 Oct;135(Pt 10):3005-14. doi: 10.1093/brain/aws234.

18.

Lewy body-related alpha-synucleinopathy in the aged human brain.

Jellinger KA.

J Neural Transm (Vienna). 2004 Oct;111(10-11):1219-35.

PMID:
15480835
19.

[A 78-year-old man with young onset parkinsonism and sudden death].

Miyasaka H, Mori H, Saikawa T, Shirai T, Kondo T, Imai H, Mizuno Y.

No To Shinkei. 1996 May;48(5):487-95. Japanese.

PMID:
8672309
20.

[Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].

Wakabayashi K, Takahashi H, Oyanagi K, Ikuta F.

No To Shinkei. 1993 Nov;45(11):1033-8. Japanese. Erratum in: No To Shinkei 1993 Dec;45(12):1133.

PMID:
8135950

Supplemental Content

Support Center